Axxcess Wealth Management, LLC Alkermes Plc. Transaction History

Axxcess Wealth Management, LLC

  • $3.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$26.4 - $32.56 $45,064 - $55,579
1,707 Added 7.56%
24,274 $657,000
Q4 2023

Feb 06, 2024
BUY
$23.37 - $28.68 $50,058 - $61,432
2,142 Added 10.49%
22,567 $626,000
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $554,947 - $652,987
20,425 New
20,425 $572,000

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email